6-bromo-N-[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl]pyridine-2-carboxamide

ID: ALA3596229

Chembl Id: CHEMBL3596229

PubChem CID: 73213293

Max Phase: Preclinical

Molecular Formula: C15H15BrN4O6

Molecular Weight: 427.21

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@H](O)[C@@H]1O)c1cccc(Br)n1

Standard InChI:  InChI=1S/C15H15BrN4O6/c16-9-3-1-2-7(18-9)13(24)17-6-8-11(22)12(23)14(26-8)20-5-4-10(21)19-15(20)25/h1-5,8,11-12,14,22-23H,6H2,(H,17,24)(H,19,21,25)/t8-,11-,12-,14-/m1/s1

Standard InChI Key:  RIZBLSQDDQJCLN-LHNIVKCTSA-N

Associated Targets(Human)

OGT Tchem UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (206 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 427.21Molecular Weight (Monoisotopic): 426.0175AlogP: -1.26#Rotatable Bonds: 4
Polar Surface Area: 146.54Molecular Species: NEUTRALHBA: 8HBD: 4
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 9.70CX Basic pKa: CX LogP: -0.71CX LogD: -0.71
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.45Np Likeness Score: -0.04

References

1. Wang S, Shen DL, Lafont D, Vercoutter-Edouart A, Mortuaire M, Shi Y, Maniti O, Girard-Egrot A, Lefebvre T, Pinto BM, Vocadlo D, Vidal S.  (2014)  Design of glycosyltransferase inhibitors targeting human O-GlcNAc transferase (OGT),  (8): [10.1039/C4MD00063C]

Source